D Bartres-Faz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

D Bartres-Faz

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 31, 1999

Transcranial magnetic stimulation: studying the brain-behaviour relationship by induction of 'virtual lesions'A Pascual-Leone, D Bartres-Faz, J P Keenan

Molecular Psychiatry|March 13, 2013

More thinking about less data: a perspective from the 2nd Provence Summer WorkshopM Valenzuela, D Bartres-Faz, E Bullmore, et al.

Drug Discovery Today. Technologies|November 2, 2013

Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humansJ Deguil, L Ravasi, A Auffret, et al.

Journal of Internal Medicine|March 5, 2016

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'S Galluzzi, M Marizzoni, C Babiloni, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 31, 1999

Transcranial magnetic stimulation: studying the brain-behaviour relationship by induction of 'virtual lesions'A Pascual-Leone, D Bartres-Faz, J P Keenan

Molecular Psychiatry|March 13, 2013

More thinking about less data: a perspective from the 2nd Provence Summer WorkshopM Valenzuela, D Bartres-Faz, E Bullmore, et al.

Drug Discovery Today. Technologies|November 2, 2013

Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humansJ Deguil, L Ravasi, A Auffret, et al.

Journal of Internal Medicine|March 5, 2016

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'S Galluzzi, M Marizzoni, C Babiloni, et al.

Pageof 1